Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

The compounds tested could potentially treat hair loss and alopecia.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Finasteride and metformin both help treat PCOS, but using them together works best.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that more research is needed to fully understand the causes of PCOS.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.